| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois
Requests for reprints: Anning Lin, Ben May Institute for Cancer Research, University of Chicago, Room N516, 5841 South Maryland Avenue, Chicago, IL 60637. Phone: 773-753-1408; Fax: 773-702-6260; E-mail: alin{at}huggins.bsd.uchicago.edu.
The phosphorylation and regulation of the proapoptotic Bcl-2 family protein BAD by c-Jun NH2-terminal kinase (JNK) is controversial. JNK can suppress interleukin-3 withdrawal-induced apoptosis via phosphorylation of BAD at Thr201. However, it has also been reported that JNK promotes apoptosis through phosphorylation of BAD at Ser128. Here, we report that JNK is not a BAD Ser128 kinase. JNK phosphorylates murine BAD (mBAD), but not human BAD (hBAD), in which Ser91 is equivalent to Ser128 in mBAD. In contrast, Cdc2, which phosphorylates Ser128, phosphorylates both mBAD and hBAD. Replacement of Ser128 by alanine has no effects on BAD phosphorylation by JNK in vitro and in vivo. Two-dimensional phosphopeptide mapping in combination with phosphoamino acid analysis reveals that JNK does not phosphorylate BAD at Ser128. Elimination of Ser128 phosphorylation has no effects on the proapoptotic activity of BAD in apoptosis induced by UV via JNK or growth factor withdrawal. Thus, our results show that Ser128 is not phosphorylated by JNK for promoting cell death.
This article has been cited by other articles:
![]() |
W. Liu, W. Li, T. Fujita, Q. Yang, and Y. Wan Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis Carcinogenesis, February 1, 2008; 29(2): 263 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bogoyevitch and B. Kobe Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1061 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, T. N. Bui, J. Xiang, and A. Lin Cyclic AMP Inhibits p38 Activation via CREB-Induced Dynein Light Chain Mol. Cell. Biol., February 15, 2006; 26(4): 1223 - 1234. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |